Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Southern California Bancorp
BCAL
$699M
| $705K | ﹤0.01% |
44,756
+16,748
| +60% | +$239K |
|
3502
Amprius Technologies
AMPX
$1.74B
| $705K | ﹤0.01% |
167,503
+131,328
| +363% | +$369K |
|
3503
CALL
Replimune Group
REPL
$1.42B
| $705K | ﹤0.01% |
+75,900
| New | +$662K |
|
3504
MeiraGTx Holdings
MGTX
$1.17B
| $705K | ﹤0.01% |
108,110
+24,345
| +29% | +$144K |
|
3505
Prothena Corp
PRTA
$466M
| $703K | ﹤0.01% |
115,848
+32,467
| +39% | +$244K |
|
3506
Oak Valley Bancorp
OVLY
$288M
| $702K | ﹤0.01% |
25,789
+5,112
| +25% | +$130K |
|
3507
LSB Industries
LXU
$711M
| $701K | ﹤0.01% |
89,814
+25,708
| +40% | +$176K |
|
3508
MaxCyte
MXCT
$149M
| $700K | ﹤0.01% |
321,231
+206,459
| +180% | +$500K |
|
3509
Eve Holding
EVEX
$976M
| $700K | ﹤0.01% |
101,978
+32,596
| +47% | +$145K |
|
3510
GoodRx Holdings
GDRX
$1.27B
| $698K | ﹤0.01% |
140,254
+164
| +0.1% | +$712 |
|
3511
ARKO Corp
ARKO
$505M
| $698K | ﹤0.01% |
165,116
+24,863
| +18% | +$109K |
|
3512
Costamare
CMRE
$1.74B
| $695K | ﹤0.01% |
76,246
-447
| -0.6% | -$3.98K |
|
3513
Meridian
MRBK
$240M
| $691K | ﹤0.01% |
53,643
+14,932
| +39% | +$197K |
|
3514
ATS Corp
ATS
$1.98B
| $690K | ﹤0.01% |
21,628
-172
| -0.8% | -$4.71K |
|
3515
OrthoPediatrics
KIDS
$653M
| $688K | ﹤0.01% |
32,028
+11,971
| +60% | +$259K |
|
3516
iQIYI
IQ
$1.31B
| $687K | ﹤0.01% |
388,332
+44,537
| +13% | +$80.1K |
|
3517
Titan Machinery
TITN
$420M
| $687K | ﹤0.01% |
34,680
+13,615
| +65% | +$249K |
|
3518
PUT
Sarepta Therapeutics
SRPT
$1.95B
| $684K | ﹤0.01% |
40,000
+15,000
| +60% | +$640K |
|
|
AARD
3519
Aardvark Therapeutics
AARD
$140M
| $684K | ﹤0.01% |
+50,558
| New | +$521K |
|
3520
CALL
Under Armour
UAA
$2.3B
| $683K | ﹤0.01% |
100,000
-400,000
| -80% | -$2.49M |
|
3521
Banco Macro
BMA
$5.14B
| $682K | ﹤0.01% |
9,718
+3,918
| +68% | +$324K |
|
3522
Vermilion Energy
VET
$1.72B
| $678K | ﹤0.01% |
93,097
+60,752
| +188% | +$415K |
|
|
YALA
3523
Yalla Group
YALA
$823M
| $676K | ﹤0.01% |
100,320
+6,804
| +7% | +$46.2K |
|
3524
Sierra Bancorp
BSRR
$532M
| $674K | ﹤0.01% |
22,718
+7,230
| +47% | +$196K |
|
3525
VTEX
VTEX
$630M
| $673K | ﹤0.01% |
+101,911
| New | +$599K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.